by Minomic | May 17, 2023
The Minomic International Ltd team was delighted to share our new findings on the application of MiCheck® Prostate with MRI-derived data at the poster presentation session at the American Urological Association’s 2023 Annual Meeting on April 28 2023 in Chicago....
by Minomic | Oct 12, 2022
SYDNEY, AUSTRALIA – Australian diagnostics company Minomic International Ltd (Minomic) is pleased to announce that their lead product, MiCheck® Prostate,1 has recorded its initial commercial sales in the US, the world’s largest healthcare market. Each year, two...
by Minomic | Apr 12, 2022
Minomic International Limited is pleased to announce that its wholly owned subsidiary, Minomic Inc., has been granted a Clinical Laboratory Improvement Amendments (CLIA) certification, allowing its lab to officially open for business, in Gaithersburg, MD. The CLIA...